| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of
*
Medicine and
Immunology, University of Colorado Health Sciences Center, Denver, CO; and
Department of Immunology, National Jewish Medical and Research Center, Denver, CO
C3dg is a cleavage product of the C3 component of complement that can facilitate the coligation of the complement receptor 2 (CR2/CD21) with the BCR via C3dg/Ag complexes. This interaction can greatly amplify BCR-mediated signaling events and acts to lower the threshold for B cell activation. Although previous studies have used anti-CR2 Abs or used chimeric Ags in the context of BCR transgenic mice as surrogate C3d-containing ligands, we have used a physiological form of C3d to study signaling in B cells from wild-type C57BL/6 mice. We find that while CR2-enhanced BCR signaling causes intracellular Ca2+ mobilization and total pTyr phosphorylation of an intensity comparable to optimal BCR ligation using anti-IgM Abs, it does so with limited activation of inhibitory effectors (such as CD22, Src homology region 2 domain containing phosphatase 1, and SHIP-1) and without substantial receptor cross-linking. In summary, we demonstrate that CR2-enhanced BCR signaling may proceed not only through the previously described amplification of positive signaling pathways, but is potentially augmented by a lack of normal inhibitory/feedback signaling.
This article has been cited by other articles:
|
|
 |
|
  K. M. Haas, J. C. Poe, and T. F. Tedder CD21/35 Promotes Protective Immunity to Streptococcus pneumoniae through a Complement-Independent but CD19-Dependent Pathway That Regulates PD-1 Expression J. Immunol., September 15, 2009; 183(6): 3661 - 3671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Barrington, T. J. Schneider, L. A. Pitcher, T. R. Mempel, M. Ma, N. S. Barteneva, and M. C. Carroll Uncoupling CD21 and CD19 of the B-cell coreceptor PNAS, August 25, 2009; 106(34): 14490 - 14495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Kulik, S. D. Fleming, C. Moratz, J. W. Reuter, A. Novikov, K. Chen, K. A. Andrews, A. Markaryan, R. J. Quigg, G. J. Silverman, et al. Pathogenic Natural Antibodies Recognizing Annexin IV Are Required to Develop Intestinal Ischemia-Reperfusion Injury J. Immunol., May 1, 2009; 182(9): 5363 - 5373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Kovacs, J. P. Hannan, E. Z. Eisenmesser, and V. M. Holers Mapping of the C3d Ligand Binding Site on Complement Receptor 2 (CR2/CD21) Using Nuclear Magnetic Resonance and Chemical Shift Analysis J. Biol. Chem., April 3, 2009; 284(14): 9513 - 9520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lyubchenko, J. P. Nielsen, S. M. Miller, G. A. Liubchenko, and V. M. Holers Role of initial protein phosphorylation events and localized release-activated calcium influx in B cell antigen receptor signaling J. Leukoc. Biol., February 1, 2009; 85(2): 298 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Malkiel, C. J. Kuhlow, P. Mena, and J. L. Benach The Loss and Gain of Marginal Zone and Peritoneal B Cells Is Different in Response to Relapsing Fever and Lyme Disease Borrelia J. Immunol., January 1, 2009; 182(1): 498 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Lyubchenko, J. M. Dal Porto, V. M. Holers, and J. C. Cambier Cutting Edge: Complement (C3d)-Linked Antigens Break B Cell Anergy J. Immunol., September 1, 2007; 179(5): 2695 - 2699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Asokan, J. Hua, K. A. Young, H. J. Gould, J. P. Hannan, D. M. Kraus, G. Szakonyi, G. J. Grundy, X. S. Chen, M. K. Crow, et al. Characterization of Human Complement Receptor Type 2 (CR2/CD21) as a Receptor for IFN-{alpha}: A Potential Role in Systemic Lupus Erythematosus J. Immunol., July 1, 2006; 177(1): 383 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Lee, K. M. Haas, D. O. Gor, X. Ding, D. R. Karp, N. S. Greenspan, J. C. Poe, and T. F. Tedder Complement Component C3d-Antigen Complexes Can Either Augment or Inhibit B Lymphocyte Activation and Humoral Immunity in Mice Depending on the Degree of CD21/CD19 Complex Engagement J. Immunol., December 15, 2005; 175(12): 8011 - 8023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. A. Mongini, J. K. Inman, H. Han, S. L. Kalled, R. J. Fattah, and S. McCormick Innate Immunity and Human B Cell Clonal Expansion: Effects on the Recirculating B2 Subpopulation J. Immunol., November 1, 2005; 175(9): 6143 - 6154. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
